Kindstar Globalgene Technology (HKG:9960) acquired a 49% equity interest in AnchorDx Inc. from AnchorDx Group HK.

The company settled the consideration for the acquisition by issuing 15,869,521 shares to WXHY Anchor Investment and 43,561,835 shares to OrbiMed Asia Partner at HK$1.42 apiece, a Friday Hong Kong bourse filing said.

Meanwhile Kindstar Global Medical Technology (Wuhan), a subsidiary of the company, also acquired 100% equity interest in Guangzhou Kangcheng Weiye Biotechnology from AnchorDx Group HK.

The group funded the acquisition consideration through internal resources and external funding.

After the completion, Guangzhou Kangcheng Weiye Biotechnology became a subsidiary of the company.